Coronavirus Update: FDA reportedly set to OK mix-and-match booster-shot approach
The U.S. death toll from the coronavirus-borne illness COVID-19 rose above 726,000 on Tuesday, as a report said the Food and Drug Administration is moving to allow people get booster shots of vaccines that are different from their primary doses.
These are Insider's biggest healthcare stories for October 19.
Johnson & Johnson plans to ask U.S. health regulators early this week to authorize a booster shot for its experimental COVID-19 vaccine, making it the third pharmaceutical company to call for extra shots, according to a report.
President Joe Biden in recent weeks has championed COVID-19 vaccine booster shots as a means of strengthening protection against the virus, but now experts are reportedly advising the president's administration to back off, arguing the science doesn't justify widespread use of the third shot.
The company last month said it provided additional data to the FDA.
Pfizer Reports Booster Shots 95.6% Effective, Offer "Favorable" Safety Profile
Appointments for health-care workers and residents
Investors are turning their focus this week on a 'make-or-break quarter' for company earnings, according to BofA Global Research.
Moderna and Johnson & Johnson booster vaccines could be with clinicians and pharmacies as early as Friday, if the CDC chief signs off.
Bloomberg reported that PayPal is considering paying $70 per Pinterest stock, putting a potential deal at about $39 billion.